Tradestie Institutional Equity Comparison Engine
MIRM vs ELVN โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
ELVN Overall Edge
ELVN Captures Institutional Edge (3โ0 Pillars ยท 4โ4 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Enliven Therapeutics, Inc. Common Stock (ELVN) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, MIRM trades at N/M Forward P/E with -21.6% operating margin (+39.6% YoY revenue) versus ELVN at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, MIRM sits in BREAKDOWN (9th %ile IV; Dealer Gamma Walls on Pro) against ELVN sits in CONSOLIDATION (5th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
MIRM N/M vs ELVN N/M Fwd P/E
Growth & Margin Winner
ELVN
Op Margin -21.6% vs 0.0% ยท YoY +39.6% vs +0.0%
Momentum & Technical Winner
ELVN
1Y +34.2% vs +134.5% ยท 52W Pos 44% vs 69%
Options & Structure Winner
ELVN
BREAKDOWN (9th %ile IV) vs CONSOLIDATION (5th %ile IV)
MIRM
NASDAQ
Mirum Pharmaceuticals, Inc. Common Stock
Pharmaceutical Preparations
$92.92
-1.14% 1D
Market Cap
$6.1B
1M Return
+15.94%
1Y Return
+34.17%
Forward P/E
N/M
Unified AI Score
38.1 / 100
SELL
Tech 8.0
Fund 37.0
Flow 71.0
Mom 40.0
ELVN
NASDAQ
Enliven Therapeutics, Inc. Common Stock
Pharmaceutical Preparations
$47.54
-2.58% 1D
Market Cap
$3.6B
1M Return
+27.38%
1Y Return
+134.53%
Forward P/E
N/M
Unified AI Score
36.2 / 100
SELL
Tech 15.0
Fund 44.0
Flow 68.0
Mom 60.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
MIRM +34.17%
ELVN +134.53%
Spread: +100.36 pp (ELVN Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
MIRM TTM Op. Margin: -21.6%
ELVN TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on MIRM vs ELVN. Trailing 12-month operating profitability (MIRM -21.6% vs ELVN 0.0%) and valuation multiples (MIRM N/M vs ELVN N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | MIRM | ELVN | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $6.1B | $3.6B | Larger Scale | MIRM |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +39.6% | +0.0% | Higher Growth | MIRM |
| Operating Margin (TTM) Profitability | -21.6% | 0.0% | Higher Margin | ELVN |
| Net Profit Margin Profitability | -134.8% | 0.0% | Higher Margin | ELVN |
| Return on Equity (ROE) Capital Efficiency | -760.0% | -16.8% | Higher ROE | ELVN |
| 52-Week Range Position Momentum | 44% ($63โ$130) | 69% ($15โ$62) | Stronger Trend | ELVN |
| Beta / 30D Volatility Risk Regime | 1.02ฮฒ ยท 49% Vol | 0.96ฮฒ ยท 60% Vol | Lower Realized Risk | MIRM |
| Unified Institutional Score Composite Signal | 38.1 / 100 (SELL) | 36.2 / 100 (SELL) | Higher Composite | MIRM |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full MIRM vs ELVN Buy Guide
MIRM
BREAKDOWN
92d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
9th %ile
IV Regime
Compressed (<25th %ile)
ELVN
CONSOLIDATION
59d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
5th %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither MIRM nor ELVN registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.